Cross-source evidence timeline

FOXO4-DRI research timeline

Follow 2 selected, directly cited source records from February 1, 2022 through July 4, 2025. This timeline joins source lanes for navigation; it does not infer that one record confirms another.

2Selected records
2Source years
1Evidence lanes
July 4, 2025Latest source date

Source year

2025

1 record
  1. Literature metadata

    The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4-DRI.↗

    PubMed lists PMID 40593617 in Nature communications as Journal Article, with publication-date metadata of 2025-07-01 (day precision). PeptideScanner associated the retained record with the identity slug foxo4-dri. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

Source year

2022

1 record
  1. Literature metadata

    Senolytic Peptide FOXO4-DRI Selectively Removes Senescent Cells From in vitro Expanded Human Chondrocytes.↗

    PubMed lists PMID 33996787 in Frontiers in bioengineering and biotechnology as Journal Article, with publication-date metadata of 2021-04-29 (day precision). PeptideScanner associated the retained record with the identity slug foxo4-dri. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗